Concepedia

Luis Aparicio

LA

13

Publications

869

Citations

11

H-Index

1983

Active since

Affiliations

Universidade da Coruña(Current)

Instituto de Investigación Biomédica de A Coruña

Hospital Universitario Central de Asturias

Howard Hughes Medical Institute

Sidney Kimmel Comprehensive Cancer Center

Luis Aparicio is an author at Universidade da Coruña specializing in medicine, cancer therapeutics, and cancer research.

ORCID

Top concepts

Publications per year

1983–2021

13

Publications

13

Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers

Justina X. Caushi, Jiajia Zhang, Zhicheng Ji et al. · Nature · 2021 · 505 citations · Full text

Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses

Arbor G. Dykema, Boyang Zhang, Bezawit A. Woldemeskel et al. · Journal of Clinical Investigation · 2021 · 92 citations · Full text

Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancer

Ángel J. Lacave, Isabel Izarzugaza, Luis Aparicio et al. · American Journal of Clinical Oncology · 1983 · 50 citations

, , +10

Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover for Metastatic Castration-Resistant Prostate Cancer

Johann S. de Bono, Josep M. Piulats, Hardev Pandha et al. · Clinical Cancer Research · 2014 · 46 citations · Full text

Cabazitaxel for metastatic castration-resistant prostate cancer: safety data from the Spanish expanded access program

Daniel Castellano, Luis Aparicio, Emilio Esteban et al. · Expert Opinion on Drug Safety · 2014 · 28 citations · Full text

Rows per page

1–5 of 13